EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) for its ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Take a look at three predictions for the year ahead for pharma executives considering AI implementation and adoption. For AI ...

Also complicating matters last year was a dispute with Shanghai biotech Nuance Pharma over a licensing agreement for otenaproxesul in the Greater China region, which resulted in an order for ...

Recent health news highlights various developments, including EssilorLuxottica's FDA clearance for Nuance audio glasses, WHO ...

AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in ...

It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well-being of all.

Investing.com -- RBC Capital Markets has upgraded EssilorLuxottica (EPA: ESLX) to "outperform," citing strong fundamentals ...

Some of the most effective leaders are understated in manner, and patient. Theirs is the pointillist approach, not the broad ...

Medi-Vantage founder and President Maria Shepherd — who's also a MedExecWomen co-founder — says DeviceTalks Boston is a ...

My patients have shared with me a newfound mistrust over the safety of all vaccines since the Covid vaccine mandates were ...

“The tariffs on Mexico and Canada is actually the worst possible news for U.S. equities and the U.S. economy,” said Thomas Brenier, head of equities at Lazard Freres Gestion. “It’s bad news for the ...